![Patrick Yue](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Yue
Keine laufenden Positionen mehr
Profil
Patrick Yue is Chief Medical Officer at Sirius Therapeutics since 2024.
Formerly, Dr. Yue was Senior Vice President-Clinical Development at Centessa Pharmaceuticals Plc from 2023 to 2024, Executive Director-Clinical Science at Global Blood Therapeutics, Inc. from 2020 to 2023, and Executive Director-Clinical Development at Portola Pharmaceuticals LLC from 2016 to 2020.
Education includes an undergraduate degree from California Institute of Technology in 1995 and a doctorate from Washington University School of Medicine in 1999.
Aktive Positionen von Patrick Yue
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von Patrick Yue
| Unternehmen | Position | Ende |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Corporate Officer/Principal | 01.06.2024 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2023 |
| PORTOLA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2020 |
Ausbildung von Patrick Yue
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
73
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
